GlassScriptPhysician profile
Lai D Brooks
NPI 1104893924
$8,814.20
in general payments reported to CMS, 2019-2025
21 companies · $1,434 in 2025
The $1,434 reported for 2025 was more than what 90% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,382 · 2022: $874 · 2023: $1,059 · 2024: $2,066 · 2025: $1,434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,559.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,558.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $3,109.06 | 2021-2025 | Valtoco |
| Ucb, INC. | $1,201.67 | 2021-2025 | Fintepla, Briviact, Nayzilam |
| Jazz Pharmaceuticals INC. | $1,013.69 | 2022-2025 | |
| Upsher-Smith Laboratories LLC | $638.05 | 2023-2025 | |
| Acadia Pharmaceuticals INC | $523.89 | 2023-2025 | Daybue |
| Livanova USA, INC. | $496.96 | 2021-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Aquestive Therapeutics, INC. | $302.38 | 2021 | |
| Sk Life Science, INC. | $244.51 | 2021-2025 | |
| Alexion Pharmaceuticals, INC. | $233.54 | 2022-2024 | Koselugo |
| Abbott Laboratories | $154.26 | 2022 | |
| Biocodex, INC. | $139.63 | 2023-2025 | Diacomit |
| Azurity Pharmaceuticals, INC. | $127.76 | 2022-2025 | Zonisade, Triptodur |
| Ptc Therapeutics, INC. | $125.00 | 2022 | |
| Catalyst Pharmaceuticals, INC. | $107.93 | 2024-2025 | |
| Itf Therapeutics LLC | $105.36 | 2024-2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $68.07 | 2021-2022 | |
| Immedica Pharma US, INC. | $64.79 | 2024-2025 | Ztalmy |
| Otter Pharmaceuticals, LLC | $55.19 | 2025 | Sympazan |
| Pyros Pharmaceuticals, INC. | $40.01 | 2024 | Vigpoder |
| Zogenix INC. | $38.29 | 2021 | |
| Supernus Pharmaceuticals, INC. | $24.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lai Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.